Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

340 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.
Baghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, Kasper S, Leonard BE, Malt UF, Stein D, Versiani M, Möller HJ; Section of Pharmacopsychiatry, World Psychiatric Association. Baghai TC, et al. Eur Arch Psychiatry Clin Neurosci. 2011 Nov;261 Suppl 3:207-45. doi: 10.1007/s00406-011-0259-6. Eur Arch Psychiatry Clin Neurosci. 2011. PMID: 22033583
Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
Saletu B, Saletu-Zyhlarz G, Anderer P, Brandstätter N, Frey R, Gruber G, Klösch G, Mandl M, Grünberger J, Linzmayer L. Saletu B, et al. Among authors: saletu zyhlarz g. Neuropsychobiology. 1997;36(3):130-52. doi: 10.1159/000119374. Neuropsychobiology. 1997. PMID: 9313245 Clinical Trial.
Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients.
Saletu-Zyhlarz GM, Anderer P, Arnold O, Saletu B. Saletu-Zyhlarz GM, et al. Among authors: saletu b. Neuropsychobiology. 2003;48(4):194-208. doi: 10.1159/000074638. Neuropsychobiology. 2003. PMID: 14673218 Clinical Trial.
Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial.
Hoever P, Dorffner G, Beneš H, Penzel T, Danker-Hopfe H, Barbanoj MJ, Pillar G, Saletu B, Polo O, Kunz D, Zeitlhofer J, Berg S, Partinen M, Bassetti CL, Högl B, Ebrahim IO, Holsboer-Trachsler E, Bengtsson H, Peker Y, Hemmeter UM, Chiossi E, Hajak G, Dingemanse J. Hoever P, et al. Among authors: saletu b. Clin Pharmacol Ther. 2012 Jun;91(6):975-85. doi: 10.1038/clpt.2011.370. Clin Pharmacol Ther. 2012. PMID: 22549286 Free PMC article. Clinical Trial.
Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder.
Saletu-Zyhlarz G, Anderer P, Brandstätter N, Dantendorfer K, Gruber G, Mandl M, Ritter K, Zoghlami A, Saletu B. Saletu-Zyhlarz G, et al. Among authors: saletu b. Neuropsychobiology. 2000;41(3):139-48. doi: 10.1159/000026646. Neuropsychobiology. 2000. PMID: 10754428 Clinical Trial.
340 results